Home › Heart Failure › North Carolina › Raleigh
Heart Failure clinical trials in Raleigh, NC
8 studies for Heart Failure are looking for participants at sites in and around Raleigh (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
RecruitingPhase 3
- WakeMed, Raleigh
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
RecruitingPhase 3
- WakeMed, Raleigh
Alleviant ALLAY-HFrEF Study
Recruiting
- NC Heart and Vascular Research, Raleigh
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
RecruitingPhase 3
- Research Site, Raleigh
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
RecruitingObservational study
- Raleigh, Raleigh
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RecruitingPhase 3
- WakeMed_Cardiology, Raleigh
Alleviant ALLAY-HF Study
Recruiting
- NC Heart and Vascular Research, Raleigh
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
RecruitingObservational study
- University of North Carolina/ Rex Hospital, Inc., Raleigh
About Heart Failure
Heart failure, or congestive heart failure (CHF), means the heart can't pump enough blood. Learn about the signs, symptoms, and causes.
More about Heart Failure on MedlinePlus
Heart Failure trials in other cities
- New York City, NY50 studies
- Boston, MA43 studies
- Dallas, TX42 studies
- Houston, TX36 studies
- Cleveland, OH33 studies
- Chicago, IL32 studies
- Philadelphia, PA31 studies
- San Francisco, CA29 studies
- St. Louis, MO26 studies
- Durham, NC26 studies
- Kansas City, MO25 studies
- Atlanta, GA25 studies
Other studies in Raleigh
- Coronary Artery Disease6 studies
- Obesity6 studies
- Macular Degeneration6 studies
- Endometrial Cancer6 studies
- Type 2 Diabetes6 studies
- Cardiovascular Disease5 studies
- Stroke5 studies
- Atherosclerosis5 studies
- Overweight5 studies
- Diabetes4 studies
- Bladder Cancer4 studies
- Geographic Atrophy4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.